Regulation of TLR3 Activation by S100A9
Su-Yu Tsai(The University of Texas at San Antonio Health Science Center), Santanu Bose(Washington State University), Swechha M. Pokharel(Washington State University), Joan Defrêne(Centre hospitalier universitaire de Québec), T. R. Kannan(The University of Texas at San Antonio Health Science Center), Nathalie Pagé(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Niraj K. Shil(Washington State University), Jesus A. Segovia(The University of Texas at San Antonio Health Science Center), Philippe A. Tessier(Université Laval), Joel B. Baseman(The University of Texas at San Antonio), Te-Hung Chang(The University of Texas at San Antonio Health Science Center), Annabelle Césaro(Université d'Orléans)
Cited by 40
Related Papers
A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease
|Nature Genetics|2011|563
Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial
|The Lancet Respiratory Medicine|2021|271
S100A8 and S100A9 Induce Cytokine Expression and Regulate the NLRP3 Inflammasome via ROS-Dependent Activation of NF-κB1
|PLoS ONE|2013|258
DAMP Molecule S100A9 Acts as a Molecular Pattern to Enhance Inflammation during Influenza A Virus Infection: Role of DDX21-TRIF-TLR4-MyD88 Pathway
|PLoS Pathogens|2014|199
Andrographolide, A Natural Antioxidant: An Update
|Antioxidants|2019|185